Sector
HealthcareOpen
₹1,007.5Prev. Close
₹1,002.8Turnover(Lac.)
₹238.07Day's High
₹1,013.9Day's Low
₹99152 Week's High
₹1,073.252 Week's Low
₹620Book Value
₹108.59Face Value
₹10Mkt Cap (₹ Cr.)
5,281.96P/E
55.16EPS
18.07Divi. Yield
2.11Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 87.14 | 71.85 | 52.9 | 52.87 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 426.67 | 449.19 | 467.8 | 392.59 |
Net Worth | 513.81 | 521.04 | 520.7 | 445.46 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 561.53 | 474.27 | 400 | 331.79 |
yoy growth (%) | 18.39 | 18.56 | 20.55 | 11.51 |
Raw materials | -165.23 | -160.55 | -112.34 | -90.84 |
As % of sales | 29.42 | 33.85 | 28.08 | 27.37 |
Employee costs | -58.82 | -56.79 | -45.75 | -32.48 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 207.38 | 161.28 | 156.33 | 150.15 |
Depreciation | -28.47 | -21.08 | -19.54 | -12.08 |
Tax paid | -55.33 | -41.51 | -32.68 | -51.92 |
Working capital | 67.33 | 22.23 | -22.08 | -14.1 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 18.39 | 18.56 | 20.55 | 11.51 |
Op profit growth | 35.19 | 2.41 | 19.92 | 21.17 |
EBIT growth | 29.52 | 2.72 | 4.7 | 31.56 |
Net profit growth | 26.95 | 50.99 | -17.4 | 105.78 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 687.35 | 571.88 | 526.67 | 588.86 | 494.62 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 687.35 | 571.88 | 526.67 | 588.86 | 494.62 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 14.83 | 9.76 | 9.6 | 29.25 | 12.43 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,266.5 | 162.98 | 1,23,107.82 | 177.39 | 0.12 | 658.7 | 85.26 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,101.5 | 78.77 | 1,02,110.83 | 333.4 | 0.39 | 2,075.3 | 607.44 |
Fortis Healthcare Ltd FORTIS | 790.7 | 465.24 | 59,709.64 | -42.23 | 0.13 | 388.47 | 120.19 |
Narayana Hrudayalaya Ltd NH | 2,073.3 | 98.14 | 42,319.04 | 159.98 | 0.22 | 919.03 | 106.95 |
Aster DM Healthcare Ltd ASTERDM | 596 | 5.25 | 30,911.1 | 61.07 | 19.88 | 573.86 | 79.8 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Company Sec. & Compli. Officer
RAMJEE DORAI
Independent Director
Indumati Gopinathan
Non-Exec & Non-Independent Dir
Dhaval Shah
Non-Exec & Non-Independent Dir
Dharmil Sheth
Chairman & MD & CEO
Rahul Guha
Non-Exec & Non-Independent Dir
Hardik Dedhia
Independent Director
Prapti Ishwar Gilada
Independent Director
Harshil Jiten Vora
Independent Director
Nishant A. Shah
Independent Director
Anandh Sundar
D-37/1 TTC Industrial Area,
MIDC Turbhe,
Maharashtra - 400703
Tel: 91-22-27622762
Website: http://www.thyrocare.com
Email: ramjee.d@thyrocare.com; enquiry@thyrocare.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Thyrocare Technologies Limited was incorporated in January, 2000. The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patien...
Read More
Reports by Thyrocare Technologies Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.